SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Weibin Wu, Bo Zhu, Xiaomin Peng, Meiling Zhou, Dongwei Jia, Jianxin Gu, Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease, Biochemical and Biophysical Research Communications, 2014, 443, 1, 68

    CrossRef

  2. 2
    Tharappel M Anil, Chandrashekaran Harish, Mudigere N Lakshmi, KrishnaReddy Harsha, Mallappa Onkaramurthy, Venkatesh Sathish Kumar, Nitya Shree, Venkatachalaiah Geetha, Gundalmandikal V Balamurali, Aralakuppe S Gopala, Bobbili Madhusudhan Reddy, Madabosse K Govind, Mammen O Anup, Yoganand Moolemath, Marikunte V Venkataranganna, Madanahalli R Jagannath, Baggavalli P Somesh, CNX-012-570, a direct AMPK activator provides strong glycemic and lipid control along with significant reduction in body weight; studies from both diet-induced obese mice and db/db mice models, Cardiovascular Diabetology, 2014, 13, 1, 27

    CrossRef

  3. 3
    Omar M. E. Abdel-Salam, Eman R. Youness, Enayat A. Omara, Amany A. Sleem, Effect of adipose tissue-derived mesenchymal stem cell treatment on oxidative stress and inflammatory response following Escherichia coli lipopolysaccharide, Comparative Clinical Pathology, 2014,

    CrossRef

  4. 4
    Ashley Eheim, Dasa Medrikova, Stephan Herzig, Immune cells and metabolic dysfunction, Seminars in Immunopathology, 2014, 36, 1, 13

    CrossRef

  5. 5
    Pranoti Mandrekar, Aditya Ambade, Immunity and inflammatory signaling in alcoholic liver disease, Hepatology International, 2014,

    CrossRef

  6. 6
    Waseem Hassan, Lin Ding, Rong-Yin Gao, Jun Liu, Jing Shang, Interleukin-6 signal transduction and its role in hepatic lipid metabolic disorders, Cytokine, 2014, 66, 2, 133

    CrossRef

  7. 7
    Mingjiang Xu, Binxia Chang, Stephanie Mathews, Bin Gao, New drug targets for alcoholic liver disease, Hepatology International, 2014,

    CrossRef

  8. 8
    Mai Duy Luu Trinh, Minh-Hiep Dinh, Dai-Hung Ngo, Dang-Khoa Tran, Quoc-Tuan Tran, Thanh-Sang Vo, Dai-Nghiep Ngo, Protection of 4-hydroxybenzyl-chitooligomers against inflammatory responses in Chang liver cells, International Journal of Biological Macromolecules, 2014, 66, 1

    CrossRef

  9. 9
    Fabio Marra, Frank Tacke, Roles for Chemokines in Liver Disease, Gastroenterology, 2014,

    CrossRef

  10. You have free access to this content10
    J C Komen, D R Thorburn, Turn up the power – pharmacological activation of mitochondrial biogenesis in mouse models, British Journal of Pharmacology, 2014, 171, 8
  11. 11
    Sanjoy Roychowdhury, Megan R. McMullen, Sorana G. Pisano, Xiuli Liu, Laura E. Nagy, Absence of receptor interacting protein kinase 3 prevents ethanol-induced liver injury, Hepatology, 2013, 57, 5
  12. 12
    Cuiqing Liu, Xiaohua Xu, Yuntao Bai, Tse-Yao Wang, Xiaoquan Rao, Aixia Wang, Lixian Sun, Zhekang Ying, Liubov Gushchina, Andrei Maiseyeu, Masako Morishita, Qinghua Sun, Jack R. Harkema, Sanjay Rajagopalan, Air Pollution–Mediated Susceptibility to Inflammation and Insulin Resistance: Influence of CCR2 Pathways in Mice, Environmental Health Perspectives, 2013,

    CrossRef

  13. 13
    David A. DeSantis, Chih-wei Ko, Yang Liu, Xiuli Liu, Amy G. Hise, Gabriel Nunez, Colleen M. Croniger, Alcohol-Induced Liver Injury Is Modulated by Nlrp3 and Nlrc4 Inflammasomes in Mice, Mediators of Inflammation, 2013, 2013, 1

    CrossRef

  14. 14
    Jan Petrasek, Timea Csak, Michal Ganz, Gyongyi Szabo, Differences in innate immune signaling between alcoholic and non-alcoholic steatohepatitis, Journal of Gastroenterology and Hepatology, 2013, 28,
  15. 15
    Xiaoni Kong, Dechun Feng, Stephanie Mathews, Bin Gao, Hepatoprotective and anti-fibrotic functions of interleukin-22: Therapeutic potential for the treatment of alcoholic liver disease, Journal of Gastroenterology and Hepatology, 2013, 28,
  16. 16
    Mark A. Barnes, Megan R. McMullen, Sanjoy Roychowdhury, Sorana G. Pisano, Xiuli Liu, Abram B. Stavitsky, Richard Bucala, Laura E. Nagy, Macrophage migration inhibitory factor contributes to ethanol-induced liver injury by mediating cell injury, steatohepatitis, and steatosis, Hepatology, 2013, 57, 5
  17. 17
    Adeline Bertola, Stephanie Mathews, Sung Hwan Ki, Hua Wang, Bin Gao, Mouse model of chronic and binge ethanol feeding (the NIAAA model), Nature Protocols, 2013, 8, 3, 627

    CrossRef

  18. 18
    Ruby L.C. Hoo, Ida P.C. Lee, Mi Zhou, Janice Y.L. Wong, Xiaoyan Hui, Aimin Xu, Karen S.L. Lam, Pharmacological inhibition of adipocyte fatty acid binding protein alleviates both acute liver injury and non-alcoholic steatohepatitis in mice, Journal of Hepatology, 2013, 58, 2, 358

    CrossRef

  19. 19
    S. Wagnerberger, L. Fiederlein, G. Kanuri, C. Stahl, G. Millonig, S. Mueller, S. C. Bischoff, I. Bergheim, Sex-Specific Differences in the Development of Acute Alcohol-Induced Liver Steatosis in Mice, Alcohol and Alcoholism, 2013, 48, 6, 648

    CrossRef

  20. 20
    Hideto Kawaratani, Tatsuhiro Tsujimoto, Akitoshi Douhara, Hiroaki Takaya, Kei Moriya, Tadashi Namisaki, Ryuichi Noguchi, Hitoshi Yoshiji, Masao Fujimoto, Hiroshi Fukui, The Effect of Inflammatory Cytokines in Alcoholic Liver Disease, Mediators of Inflammation, 2013, 2013, 1

    CrossRef

  21. 21
    Esther Rodríguez-Gallego, Marta Riera-Borrull, Anna Hernández-Aguilera, Roger Mariné-Casadó, Anna Rull, Raúl Beltrán-Debón, Fedra Luciano-Mateo, Javier A. Menendez, Alejandro Vazquez-Martin, Juan J. Sirvent, Vicente Martín-Paredero, Angel L. Corbí, Elena Sierra-Filardi, Gerard Aragonès, Anabel García-Heredia, Jordi Camps, Carlos Alonso-Villaverde, Jorge Joven, Ubiquitous Transgenic Overexpression of C-C Chemokine Ligand 2: A Model to Assess the Combined Effect of High Energy Intake and Continuous Low-Grade Inflammation, Mediators of Inflammation, 2013, 2013, 1

    CrossRef

  22. 22
    Jan Petrasek, Timea Csak, Gyongyi Szabo, 2013,

    CrossRef

  23. 23
    D. Degré, A. Lemmers, T. Gustot, R. Ouziel, E. Trépo, P. Demetter, L. Verset, E. Quertinmont, V. Vercruysse, O. Le Moine, J. Devière, C. Moreno, Hepatic expression of CCL2 in alcoholic liver disease is associated with disease severity and neutrophil infiltrates, Clinical & Experimental Immunology, 2012, 169, 3
  24. 24
    Jan Petrasek, Shashi Bala, Timea Csak, Dora Lippai, Karen Kodys, Victoria Menashy, Matthew Barrieau, So-Yun Min, Evelyn A. Kurt-Jones, Gyongyi Szabo, IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice, Journal of Clinical Investigation, 2012, 122, 10, 3476

    CrossRef

  25. 25
    H. Joe Wang, Bin Gao, Samir Zakhari, Laura E. Nagy, Inflammation in Alcoholic Liver Disease, Annual Review of Nutrition, 2012, 32, 1, 343

    CrossRef

  26. 26
    Xiaobing Dou, Songtao Li, Zhigang Wang, Dongfang Gu, Chen Shen, Tong Yao, Zhenyuan Song, Inhibition of NF-κB Activation by 4-Hydroxynonenal Contributes to Liver Injury in a Mouse Model of Alcoholic Liver Disease, The American Journal of Pathology, 2012, 181, 5, 1702

    CrossRef

  27. 27
    Y. Nio, T. Yamauchi, M. Iwabu, M. Okada-Iwabu, M. Funata, M. Yamaguchi, K. Ueki, T. Kadowaki, Monocyte chemoattractant protein-1 (MCP-1) deficiency enhances alternatively activated M2 macrophages and ameliorates insulin resistance and fatty liver in lipoatrophic diabetic A-ZIP transgenic mice, Diabetologia, 2012, 55, 12, 3350

    CrossRef

  28. You have free access to this content28
    Hong ZHU, Zhenquan JIA, Hara MISRA, Y Robert LI, Oxidative stress and redox signaling mechanisms of alcoholic liver disease: Updated experimental and clinical evidence, Journal of Digestive Diseases, 2012, 13, 3